AZIENDA ULSS N3 SERENISSIMA
Desconocido
RealHOPE: Real World Handling of Protein Drugs Exploration Evaluation and Education
AZIENDA ULSS N3 SERENISSIMA
participó en un
H2020:
H2020-JTI-IMI2-2020-20-two-stage
RealHOPE will create an understanding of the real-life handling of protein drugs in hospital pharmacy, clinics and in the hands of patients...
2021-07-05 - 2025-06-30 | Financiado
2021-07-05 - 2025-06-30 | Financiado
REVERT: taRgeted thErapy for adVanced colorEctal canceR paTients
AZIENDA ULSS N3 SERENISSIMA
participó en un
H2020:
H2020-SC1-BHC-2018-2020
The REVERT project will address the specific challenge of understanding at system level the pathophysiology of mCRC cancer in patients respo...
2019-11-22 - 2024-12-31 | Financiado
2019-11-22 - 2024-12-31 | Financiado
* No se disponen de datos de la empresa actual.